To The Moon

AI is the way forward 

I’ve been buying $Tempus AI(TEM)$ in the $40 range I think this stock can do some big gains based on AI growing at a rapid pace and this specifically being in the healthcare field plus they are receiving government grants and the best trader on the planet Nancy Pelosi is in.

Traders May Finally get the chance to BUY $Tempus AI(TEM)$ at same cost level as Nancy Pelosi likely today

$Tempus AI(TEM)$ TEM’s AI-driven health solutions are driving strong revenue growth, backed by rising demand for precision medicine and diagnostics. Its expanding market share and improving margins reinforce confidence in future profitability. With continued innovation and strategic partnerships, earnings should support high estimates, keeping investor sentiment bullish.

$Tempus AI(TEM)$ TEM's earnings outlook remains robust, supporting high estimates, especially within the AI + health sector. Here’s why:1. AI Integration in Healthcare: TEM’s focus on integrating AI into healthcare solutions positions it well for growth. As AI continues to revolutionize diagnostics, treatment recommendations, and patient management, TEM stands to benefit from expanding market opportunities, especially in telemedicine and AI-driven medical tools.2. Strong Earnings Growth: TEM has shown consistent earnings growth, with solid performance in both AI and healthcare segments. This foundation gives confidence that the company can meet or exceed analyst estimates. The scalability of their AI-powered solutions also

Click to vote! Predict how $Tempus AI(TEM)$ will close on Tuesday, February 25th, after their earnings report. If you get the correct answer, you’ll share 1,000 Tiger Coins with other Tigers!📊 Tempus AI Q4 Earnings Report Preview $Tempus AI(TEM)$ will release its Q4 2024 earnings report after the U.S. market closes on February 24. Market estimates indicate:Revenue: $203 millionAdjusted Net Loss: $30.93 millionAdjusted EPS: -$0.167Since its IPO in June 2024, Tempus AI’s stock has experienced extreme volatility. The stock surged to nearly $80 per share in November before declining sharply, losing over half its market value. However, recent backing from high-profile investors like Nancy Pelosi and Cathie Wood

Hello everyone! Today i want to share some trading ideas with you!1. $Hims & Hers Health Inc.(HIMS)$ is following the $Amazon.com(AMZN)$ playbook:More, cheaper, faster…It’s rapidly launching into new markets, offering cheaper prices and you can get your personalized treatment in days.This is a powerful growth engine. $Hims & Hers Health Inc.(HIMS)$ will be a $100 billion company.2. $MercadoLibre(MELI)$ and $Nu Holdings Ltd.(NU)$ both are still amazing opportunities. $MercadoLibre(MELI)$ still has 15 more countries to expand to in

💰 In the world of short-term investing, stories, news, and unexpected events are the secrets of investing.💹 Event-driven markets usually last for a few days or less. As long as you are not the last one to get on the train, you will not lose money, but this requires the ability to resist greed.📣 Stay tuned and supercharge purchasing power with CashBoost!IntroductionAs the penetration rate of AI in the industry continues to increase, more and more industries have announced the use of AI to empower their own businesses, such as AI Powered Healthcare, AI Powered Education, etc.Last week, on February 13, President Trump signed an executive order to establish the "MAHA" (Make America Healthy Again) committee. Although Trump is known for his "around-the-clock" governance style, with his "Twitter-

It's about time. Cyclic stocks and is the season for healthcare stocks especially those backed by politicians. TEM is going to be on a 1000% run by 2025 I reckon and this kind of momentum will pull the class up. RXRX is already an established stock that's been traded for years on promise of up side. This $NVDA news is all out needs to become the next Soundhound. Still good buying opportunities at the moment. Get in. #LFG!

qqq good

ffyu

fguiifj

$HIMS 20250221 53.0 PUT$ closed. 

$Tempus AI(TEM)$  🚨 Tempus AI (TEM) – Overhyped or the Next Big Thing? 🚨 🔥 Tempus AI is soaring at $91 (highest point), but is the hype justified? Here’s the REAL breakdown: 📉 Fundamentals Say SELL 🔹 P/S Ratio: 20.6x (Industry Avg: 8x) 🔹 EV/Revenue: 27.5x (More than double high-growth AI stocks) 🔹 Massive overvaluation compared to Palantir, Datadog & Recursion Pharma 📊 Fair Value Estimate: $32 Based on Q2 & Q3 2024 reports, the stock should trade between $20-$48 – meaning a 63% downside risk from current levels! 🚀 Hype or Reality? Yes, AI & Healthcare Data is the future, but can Tempus AI justify this valuation? If growth slows, a major correction is coming. 💡 What’s your take? Is TEM a Buy, Hold, or Sell?

$Recursion Pharmaceuticals, Inc.(RXRX)$ $Absci Corporation.(ABSI)$

$TEM 20250417 45.0 CALL$ one more week before WE ROLL ❤️‍🔥🌿🤟😜 #LFG

Great Job for China seeing all the stock in bullish

$TEM  This one has been great. Admitted....this is the first ticker I admit that I instantly bought as soon as PR came out about someone buying (Pelosi's husband). I would put any amount that he/she are not going to invest 'unless they know...with the inside scoop'. Now playing on house money so to speak. It will be interesting how much further it goes. While Pelosi's investment was notable...it was not what some would consider a 'huge amount'. Expecting a decent pull back at some point soon.

$Hims & Hers Health Inc.(HIMS)$ HIMS has a PER of 137 and a forecast PER of over 100. So, I'm starting to feel that this level is a bit tough given the forecast EPS growth rate. Will it go up even if the financial results are good? I'm prepared for a backlash... Thinking about it now, I wonder what that PER of 44 after the last November financial results was all about. (Super lucky)

$Amazon.com(AMZN)$ $Palantir Technologies Inc.(PLTR)$ $Hims & Hers Health Inc.(HIMS)$ Have You Ever Skipped a Stock Because It Looked Overvalued? Have you ever passed on a stock like Amazon, Him & Hers, Palantir, SoFi, or any other growth company just because it seemed too expensive? Maybe it was trading at 80, 100, or even 120 times earnings, and you dismissed it as overvalued—only to look back a few years later and see the stock continuing to climb? Even as these companies remain "overvalued," trading at high multiples like 60, 70, or 80 times earnings, their stock prices keep rising. This leads to two common conclusions: The Bubble Theory – Many tradit

💰 In the world of short-term investing, stories, news, and unexpected events are the secrets of investing.💹 Event-driven markets usually last for a few days or less. As long as you are not the last one to get on the train, you will not lose money, but this requires the ability to resist greed.📣 Stay tuned and supercharge purchasing power with CashBoost!IntroductionAs the penetration rate of AI in the industry continues to increase, more and more industries have announced the use of AI to empower their own businesses, such as AI Powered Healthcare, AI Powered Education, etc.Last week, on February 13, President Trump signed an executive order to establish the "MAHA" (Make America Healthy Again) committee. Although Trump is known for his "around-the-clock" governance style, with his "Twitter-

💰 U.S. market maintains upward trajectory, with Meta setting a new record — rising for 19 consecutive trading days.💹 $Airbnb, Inc.(ABNB)$ , $Upwork Inc.(UPWK)$ , and $Fiverr International Ltd.(FVRR)$ are emerging as highly attractive opportunities, offering substantial value for investors.📣Stay tuned, supercharge purchasing power through CashBoost!————————————————————————————————————————————————| Market recapThe U.S. stock market opened strong and closed higher across all three major indices. $Meta Platforms, Inc.(META)$ continues its impressive upward streak, breaking records with 19 consecutive days of gains. Additiona

$Amazon.com(AMZN)$ $Palantir Technologies Inc.(PLTR)$ $Hims & Hers Health Inc.(HIMS)$ Have You Ever Skipped a Stock Because It Looked Overvalued? Have you ever passed on a stock like Amazon, Him & Hers, Palantir, SoFi, or any other growth company just because it seemed too expensive? Maybe it was trading at 80, 100, or even 120 times earnings, and you dismissed it as overvalued—only to look back a few years later and see the stock continuing to climb? Even as these companies remain "overvalued," trading at high multiples like 60, 70, or 80 times earnings, their stock prices keep rising. This leads to two common conclusions: The Bubble Theory – Many tradit

Industry-Leading Growth & Innovation $Hims & Hers Health Inc.(HIMS)$  is not just another name in the telehealth space; it's a beacon of innovation and growth, boasting the fastest revenue growth in its sector. With a revenue surge to $401.6 million in Q3, up 77% year-over-year, Hims is on a trajectory that could see its value triple, if not more. This growth is underpinned by a unique business model: Direct-to-Consumer (DTC) Focus targeting Millennials & Gen Z. Specialized Services in telemedicine, weight loss, hair loss, skincare, sexual health, and mental health. One-Stop Healthcare solution with its online pharmacy, handling consultation to prescription fulfillment. Personalized Treatment using A

The rise of artificial intelligence (AI) has already transformed industries, but a new wave of innovation—agentic AI—is emerging as a game-changer. Unlike traditional AI systems that follow predefined rules or react to inputs, agentic AI refers to autonomous systems capable of making decisions, learning dynamically, and acting independently in complex environments. From healthcare to logistics, companies leveraging agentic AI are positioned to disrupt markets and generate outsized returns. In this article, I would like to discuss why agentic AI stocks are set to thrive in the coming decade. The Evolution from Assistive to Autonomous AI Traditional AI excels at pattern recognition (e.g., ChatGPT for text generation), but agentic AI goes further by enabling machines to set goals, adapt to un

AI is no longer creeping into healthcare -- it’s bulldozing through it, forcing a fundamental reset of how medicine is developed, delivered, and monetized. Investors are no longer speculating; they’re reallocating capital toward the companies driving this shift, and the market is rewarding them in 2025. This isn’t just a temporary wave -- it’s a structural repricing of healthcare’s future.The forces at play go beyond balance sheets and earnings calls. AI is now an operational necessity in healthcare, and policy shifts are accelerating its adoption. The speculation surrounding RFK Jr. as Trump’s potential HHS secretary has injected a fresh dose of bullishness into the space, as investors price in a pro-innovation regulatory environment that could remove bottlenecks slowing AI integration. M

In recent years, particularly during the economic turbulence caused by the global health crisis, options trading has surged in popularity among retail investors in the United States. Data from the Options Clearing Corporation shows that during the peak of the epidemic, the volume of options traded soared, with daily average trading volumes in 2020 increasing by about 50% compared to the previous year. However, this increase in activity has not universally led to success; statistics suggest that approximately 80% of retail options traders end up losing money, with average losses often exceeding initial investments by significant margins. According to a 2022 report by the Financial Industry Regulatory Authority (FINRA), only about 20% of retail investors consistently profited from optio

Click to vote! Predict how $Tempus AI(TEM)$ will close on Tuesday, February 25th, after their earnings report. If you get the correct answer, you’ll share 1,000 Tiger Coins with other Tigers!📊 Tempus AI Q4 Earnings Report Preview $Tempus AI(TEM)$ will release its Q4 2024 earnings report after the U.S. market closes on February 24. Market estimates indicate:Revenue: $203 millionAdjusted Net Loss: $30.93 millionAdjusted EPS: -$0.167Since its IPO in June 2024, Tempus AI’s stock has experienced extreme volatility. The stock surged to nearly $80 per share in November before declining sharply, losing over half its market value. However, recent backing from high-profile investors like Nancy Pelosi and Cathie Wood

Hims & Hers Stock Is On Fire. Is It a Meme? $Hims & Hers Health Inc.(HIMS)$ has been in the Asymmetric Universe since May 24, 2024, when this Spotlight article was published. I thought the company had 10x potential over the next decade, disrupting how we think about getting medicine in an internet world.What I didn’t expect was for shares to be up 258.2% in just under 9 months and 142.1% this year alone.Has the stock become a meme? Is buying now crazy? Or is the rocket ship just taking off?Hims & Hers Growth Is Out of This WorldSince 2018, Hims & Hers has grown revenue at a 95% compound annual growth rate and expects to grow revenue 90% this quarter. There aren’t many companies growing that fast and improving profitability at the s

AI is the way forward 

I’ve been buying $Tempus AI(TEM)$ in the $40 range I think this stock can do some big gains based on AI growing at a rapid pace and this specifically being in the healthcare field plus they are receiving government grants and the best trader on the planet Nancy Pelosi is in.

Some argue that options trading is inherently risky, especially for beginners who lack a clear understanding of how it works. For them, venturing into options without proper knowledge is akin to gambling.However, for Nancy Pelosi, options may well represent long-term investments.Take her most recent disclosures on January 17, for example. She executed in-the-money call options on several tech stocks.She purchased: - 50 $Alphabet(GOOG)$ $150 1/16/26 calls - Exercised her 500 $NVIDIA(NVDA)$ calls (purchased 50,000 shares) - Exercised her 140 $Palo Alto Networks(PANW)$ calls (purchased 14,000 shares) - 50 $Tempus AI(TEM)$ $2

Traders May Finally get the chance to BUY $Tempus AI(TEM)$ at same cost level as Nancy Pelosi likely today

1. Pelosi makes a ton of new trades before Trumps inauguration day!According to Securities and Exchange Commission (SEC) files:$Alphabet(GOOG)$ Buy (Call) / $250K - $500K / Purchased 50 call options, strike price $150, exp. date 1/16/26$Amazon.com(AMZN)$ Buy (Call) / $250K - $500K / Purchased 50 call options, strike price $150, exp. date 1/16/26$NVIDIA(NVDA)$ Buy (Call) / $250K - $500K / Purchased 50 call options, strike price $80, exp. date 1/16/26$Vistra Energy Corp.(VST)$ Buy (Call) / $500K - $1M / Purchased 50 call options, strike price $50, exp. date 1/16/26$Tempus AI(TEM

1. $Alphabet(GOOG)$ $Alphabet(GOOGL)$ 🚨 GOOGLE pulling back into the weekly market bias—trading near a discounted range.✅ BX Trender on the daily made higher lows yesterday—a sign that short-term buyers are stepping in.✅ If momentum holds, we could see a push back to $200.❌ I haven’t taken a position yet but considering adding it to the weekly watchlist.Image2. $Hims & Hers Health Inc.(HIMS)$ 🚀 HIMS is up 151% since the callout.Through the lens of proper risk management, it’s never a bad idea to start locking in profits when a stock is this far from the weekly market bias.✅ You will never go broke taking profits.Are you trimming here or letting it ride? 👇3.

$Tempus AI(TEM)$ $SUPER MICRO COMPUTER INC(SMCI)$ 📈🅱️ U͛ L͛ L͛ I͛ S͛ H͛🔺💹  🎯🎉 $TEM: The Biotech Vanguard I Identified First, AI Innovation Meets Pelosi’s Power Strategy, Echoing SMCI’s Ascendancy! 🎉🎯 Tiger Traders, back on 11Dec24, I spotlighted $TEM as more than just a stock, it was a harbinger of change. Now, with the industry’s eyes on it, $TEM is not just innovating, it’s leading a healthcare revolution, reminiscent of SMCI’s transformative journey in tech. 📈 TEM’s Unparalleled Ascendancy: 1️⃣ Pharma’s Cornerstone: Tempus isn’t merely contributing, it’s orchestrating the future of drug development for 95% of the globe’s pharmaceutical leaders. This isn’t just influence, it’s control. 🌍💊 2️⃣ AI Hea

$Tempus AI(TEM)$ TEM's earnings outlook remains robust, supporting high estimates, especially within the AI + health sector. Here’s why:1. AI Integration in Healthcare: TEM’s focus on integrating AI into healthcare solutions positions it well for growth. As AI continues to revolutionize diagnostics, treatment recommendations, and patient management, TEM stands to benefit from expanding market opportunities, especially in telemedicine and AI-driven medical tools.2. Strong Earnings Growth: TEM has shown consistent earnings growth, with solid performance in both AI and healthcare segments. This foundation gives confidence that the company can meet or exceed analyst estimates. The scalability of their AI-powered solutions also

‌$Tempus AI(TEM)$  ‌ Tempus AI: Balancing Innovation and Profitability – Is It Time to Buy, Hold, or Sell? Here's the approach: Evaluate Financial Position: Analyze Tempus AI’s revenue growth, profitability, cash reserves, and spending patterns (e.g., R&D, stock-based compensation). Consider Strategic Developments: Assess recent news, including the Ambry Genetics acquisition and product launches, to understand how they enhance Tempus’ competitive edge. Compare Market Price to Valuation: Use the company’s performance metrics and the stock’s current price ($47.64) to judge whether it’s undervalued, fairly priced, or overvalued. Risk Analysis: Identify key risks (e.g., declining genomics margins, operational losses) to gauge long-term sustain

$Alphabet(GOOGL)$ $Amazon.com(AMZN)$ $Apple(AAPL)$ $NVIDIA(NVDA)$ 🚀💼🧠 Decoding Pelosi’s Portfolio, A Masterclass in Strategic Trading 🧠💼🚀 Nancy Pelosi’s recent financial disclosures reveal an investment strategy steeped in foresight, focusing heavily on tech powerhouses and the burgeoning AI revolution. Let’s dive into the moves that are shaping her portfolio, and perhaps the market’s direction: 📊 Strategic Transactions • Alphabet (GOOGL): Secured 50 call options at a $150 strike price, expiring on 16Jan26, signalling her long-term confidence in Alphabet’s dominance in AI and search technologies. • Amazon (AMZN): Anothe

$Tempus AI(TEM)$ $Vistra Energy Corp.(VST)$ 🌌💰💼 When Fortune Aligns with Strategy 💼🌌💰 Nancy Pelosi’s recent stock selections; $TEM (Tempus AI) and $VST (Vistra Corp), may reflect either strategic foresight or a fortuitous alignment with rapidly emerging market trends. 🔍 $TEM (Tempus AI) Tempus AI stands at the forefront of AI-driven healthcare innovation, perfectly positioned within the framework of the $500 billion Stargate Project, which aims to revolutionise healthcare through AI integration. The project’s first AI-enabled data centre is set to launch in Abilene, Texas, ushering in a new era for medical technology. However, recent insider activity warrants attention:    •